AR and pachyonychia congenita: In addition to its antiproliferative activity in the low micromolar range against several cancer cell lines, including androgen-independent and androgen-dependent PC cell lines, RM-581 has been shown to be highly active (IC50~0.5 μM) on the AR+ metastatic LAPC-4 cell line used in the present study.